Iron management in predialysis patients

Seminars in Dialysis

Volumn 12, Issue 4, 1999, Pages 262-266

  Silverberg, Donald S ^a   Blum, Miriam ^a   Schwartz, Doron ^a   Agbaria, Zodi ^a   Yacnin, Tatiana ^a   Steinbruch, Shoshana ^a   Baruch, Roni ^a   Laina, Adrian ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000823433     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-139x.1999.99031.x     Document Type: Article

References (21)

1. Durand-Zaleski I, Goldfarb B, Blum-Boisgard C, Drueke T, Kreis H: Cost of treating predialysis patients with recombinant human erythropoietin. Nephrol Dial Transplant 8:311-314, 1993
2. Jungers P, Zingraff J, Albouze G, Chauveau P, Page T, Hannedouche T, Man NK: Late referral to maintenance dialysis: Detrimental consequences. Nephrol Dial Transplant 8:1089-1093, 1993
3. Ifudu O, Dawood M, Homei P, Friedman EA: Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis 28:841-845, 1996
4. Joki N, Hase H, Nakamura R, Yamaguchi T: Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant 12:718-723, 1997
5. Hakim RM, Lazarus JM: Biochemical parameters in chronic renal failure. Am J Kidney Dis 11:238-247, 1988
6. Greaves SC, Gamble DG, Collins JF, Whalley GA, Sharpe DM: Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure. Am J Kidney Dis 24:768-776, 1994
7. Levin A, Singer J, Thompson CR, Ross H, Lewis M: Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 27:347-354, 1996
8. Tucker B, Fabbian F, Giles M, Thuraisingham RC, Raine AEG, Baker LRI: Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure. Nephrol Dial Transplant 12:724-728, 1997
9. Katz AM: The cardiomyopathy of overload: An unnatural growth response in the hypertrophied heart. Ann Intern Med 121:363-371, 1994
10. Johnson DB, Dell'Italia LJ: Cardiac hypertrophy and failure in hypertrophy. Curr Opin Nephrol Hypertens 5:186-191, 1996
11. London GM, Parfrey PS: Cardiac disease in chronic uremia: Pathogenesis. Adv Ren Replace Ther 4:194-211, 1997
12. Portoles J, Torralbo A, Martin P, Rodrigo J, Herrero JA, Barrientos A: Cardiovascular effects of recombinant human erythropoietin in predialysis patients. Am J Kidney Dis 29:541-548, 1997
13. Mocks J, Franke W, Ehmer B, Scigalla P, Quarder O: Analysis of safety database for long-term epoetin-beta treatment: a meta-analysis covering 3,697 patients, in Pathogenetic and Therapeutic Aspects of Chronic Renal Failure, edited by Koch KM, Stein G. New York: Marcel Dekker, 1997, pp. 163-179
14. Silverberg DS, Blum M, Peer G, laina A: Anemia during the predialysis period: A key to cardiac damage in renal failure. Nephron 80:1-5, 1998
15. Silverberg DS, laina A, Peer G, Kaplan E, Levi B-A, Frank N, Steinbruch S, Blum M: Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure in patients not receiving dialysis. Am J Kidney Dis 27:234-238, 1996
16. Fudin R, Jaichenko J, Shostak A, Bennett M, Gotloib L: Correction of uremic iron deficiency in hemodialyzed patients. A prospective study. Nephron 79:299-305, 1998
17. Gotloib L, Ludicer H, Mines M, Ackerman J: Iron storage in chronic uremic undialyzed patients. Dial Transplant 12:442B-442E, 1983
18. Schustack A, Meshiaj D, Waiss Z, Gotloib L: Intramuscular iron replenishment and replacement combined with testosterone enanthate in maintenance hemodialysis anemia: A follow-up of up to 8 years on 16 patients. Clin Nephrol 23:303-306, 1985
19. Wadgymar A, Moore E, Stockall C, Searger M: Management of anemia in predialysis patients. J Am Soc Nephrol 7:79A, 1997
20. Austrian Multicenter Study Group of r-HuEPO in Predialysis Patients: Effectiveness and safety of recombinant human erythropoietin in predialysis patients. Nephron 61:399-403, 1992
21. Roth D, Smith RD, Schulman G, Steinman TI, Hatch FE, Rudnick MR, Sloand JA, Freedman BI, Williams WW, Shadur CA, Benz RL, Teehan BP, Revicki DA, Sarokan BJ, Abels RI: Effect of recombinant erythropoietin on renal function in chronic renal failure predialysis patients. Am J Kidney Dis 24:777-784, 1994